MacroGenics Inc. (MGNX)
MacroGenics Statistics
Share Statistics
MacroGenics has 63.09M shares outstanding. The number of shares has increased by 0.73% in one year.
| Shares Outstanding | 63.09M |
| Shares Change (YoY) | 0.73% |
| Shares Change (QoQ) | 0.52% |
| Owned by Institutions (%) | 89.21% |
| Shares Floating | 58M |
| Failed to Deliver (FTD) Shares | 57 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 5.28M, so 8.41% of the outstanding shares have been sold short.
| Short Interest | 5.28M |
| Short % of Shares Out | 8.41% |
| Short % of Float | 9.12% |
| Short Ratio (days to cover) | 10.89 |
Valuation Ratios
The PE ratio is -3.04 and the forward PE ratio is -1.17. MacroGenics's PEG ratio is 0.
| PE Ratio | -3.04 |
| Forward PE | -1.17 |
| PS Ratio | 1.36 |
| Forward PS | 0.9 |
| PB Ratio | 1.75 |
| P/FCF Ratio | -2.82 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MacroGenics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.32.
| Current Ratio | 3.92 |
| Quick Ratio | 3.92 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | -0.65 |
| Debt / FCF | -0.52 |
| Interest Coverage | -99.17 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $439.77K |
| Profits Per Employee | $-196.38K |
| Employee Count | 341 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 944K |
| Effective Tax Rate | -1.43% |
Stock Price Statistics
The stock price has increased by -92.44% in the last 52 weeks. The beta is 2.23, so MacroGenics's price volatility has been higher than the market average.
| Beta | 2.23 |
| 52-Week Price Change | -92.44% |
| 50-Day Moving Average | 2.1 |
| 200-Day Moving Average | 3.28 |
| Relative Strength Index (RSI) | 32.03 |
| Average Volume (20 Days) | 780.02K |
Income Statement
In the last 12 months, MacroGenics had revenue of 149.96M and earned -66.97M in profits. Earnings per share was -1.07.
| Revenue | 149.96M |
| Gross Profit | 149.12M |
| Operating Income | -110.58M |
| Net Income | -66.97M |
| EBITDA | -57.37M |
| EBIT | -64.91M |
| Earnings Per Share (EPS) | -1.07 |
Balance Sheet
The company has 182.84M in cash and 37.46M in debt, giving a net cash position of 145.38M.
| Cash & Cash Equivalents | 182.84M |
| Total Debt | 37.46M |
| Net Cash | 145.38M |
| Retained Earnings | -1.17B |
| Total Assets | 261.65M |
| Working Capital | 161.96M |
Cash Flow
In the last 12 months, operating cash flow was -68.37M and capital expenditures -3.71M, giving a free cash flow of -72.08M.
| Operating Cash Flow | -68.37M |
| Capital Expenditures | -3.71M |
| Free Cash Flow | -72.08M |
| FCF Per Share | -1.15 |
Margins
Gross margin is 99.44%, with operating and profit margins of -73.74% and -44.66%.
| Gross Margin | 99.44% |
| Operating Margin | -73.74% |
| Pretax Margin | -44.03% |
| Profit Margin | -44.66% |
| EBITDA Margin | -38.25% |
| EBIT Margin | -73.74% |
| FCF Margin | -48.06% |
Dividends & Yields
MGNX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for MGNX is $5, which is 290.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $5 |
| Price Target Difference | 290.6% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
Scores
| Altman Z-Score | -5.48 |
| Piotroski F-Score | 1 |